Upload
others
View
2
Download
0
Embed Size (px)
Citation preview
Car
ollo
Tem
plat
eWat
erW
ave.
pptx
/1
Integrating Nutrient and Trace Organic Removal in Wastewater
Treatment WERF CEC4R08
9th IWA Leading-Edge Conference, June 3-7
Tanja Rauch-Williams, Andrew Salveson Carollo Engineers Eric Dickenson
Southern Nevada Water Authority Drew McAvoy
University of Cincinnati Jörg Drewes
Colorado School of Mines Douglas Drury
Clark County Water Reclamation District
Car
ollo
Tem
plat
eWat
erW
ave.
pptx
/2
How Do Process Upgrades for Nutrient Removal Effect TOrC?
Car
ollo
Tem
plat
eWat
erW
ave.
pptx
/3
Trace Organic Challenge
• Numerous and diverse known and unknown chemicals used in high quantities
• Adverse effects of trace organic compounds (TOrC) on aquatic life in receiving waters
• Sewage systems not designed for TOrC removal
• Regulatory requirements world-wide in development
Regulatory Developments Related to TOrC Region/Country Regulatory Development
United States
• Contaminant Candidate List 3 (2009, every 5 years): 10 pharmaceuticals, 9 hormones • Unregulated Contaminant Monitoring Regulation (UCMR3) (2012): Screening for 7 hormones
Oregon SB737 - Municipal Persistent Pollutant Reduction Plans
California Recycled Water Policy: Monitoring Strategy for Water Reuse (2012)
Massachusetts Emerging Contaminant Screening Process
European Union
• REACH Directive (2007) • Compound-specific bans (e.g., Phtalates, nonylphenol) • Proposed change of ‘Directive on priority substances in the field of water quality’ (2012): 17 alpha-ethinylestradiol (EE2), 17 beta-estradiol (E2), Diclofenac. • Watershed specific strategies (2007, 2011): Rhine, Lake Geneva
Switzerland • Regulation Proposal to Finance WWTP Upgrades for TOrC Removal (2012)
Car
ollo
Tem
plat
eWat
erW
ave.
pptx
/5
WERF’s Emphasis of TOrC Research
TOrC Challenge Program
Ecological Impact
Public Perception Treatability
Car
ollo
Tem
plat
eWat
erW
ave.
pptx
/6
Indicator Compounds for Treatment Assessment
242 TOrC Evaluated
Selection Criteria • Occurrence • Analytical amenability • Bio-physicochemical properties • Toxicological relevance Ca. 20 TOrC
Full-Scale Monitoring
SE 37.7 mgdPE 36.4 mgd liquid 180 ng/Lliquid 190 ng/L 25.7 g/d
26.2 g/d solid 13 ng/gsolid 0 ng/g 0.02 g/d
0 g/dRAS 25 mgdliquid 217 ng/L
20.5 g/dsolid 13 ng/g
1.2 g/dWAS 0.29 mgdliquid 217 ng/L
0.2 g/dsolid 13 ng/L
0.0 g/d
SC Aeration Basins
TOrC Removal (biodegradation / sorption) as function of process characteristics
Car
ollo
Tem
plat
eWat
erW
ave.
pptx
/7
Categorizing Selected TOrC Indicators
liquidTOrC
solidTOrCd C
CK
,
,=
TOrC
TOrCbToRC CKdt
dC−=
Biotransformation Sorption Biotransformation Rate Sorption Coefficient
Car
ollo
Tem
plat
eWat
erW
ave.
pptx
/8
Indicator Matrix to Benchmark Treatment Performance
Biotransformation (Kb, L/g-d)
Recalcitrant <0.1
Moderate Slow 0.1-10
Rapid >10
Sorp
tion
(log
Kd)
Low
<2
.5
Carbamazepine Meprobamate
Primidone TCEP
Sucralose
DEET Sulfamethoxazole
Gemfibrozil Iopromide
Acetaminophen Caffeine
Naproxen Ibuprofen Atenolol
Sorp
tive
2.5-
3
TCPP Cimetidine Trimethoprim
Benzophenone Diphenhydramine
Bisphenol A
Effe
ctiv
e >3
Triclocarban
Triclosan Fluoxetine
Faster transformation during secondary treatment
Hig
her s
orpt
ion
durin
g se
cond
ary
treat
men
t
Car
ollo
Tem
plat
eWat
erW
ave.
pptx
/9
Influent
Influent
Preliminary Treatment
Primary Clarification
Aeration Basins
Secondary Clarification
Chlorination
RAS
Effluent
Primary Sludge
Waste Activated Sludge
Process Upgrades to Enhance Nutrient Removal
P removal Anaerobic
Alternative Disinfection
(UV, O3)
Larger Basins / Denser Footprints (e.g., MBR, IFAS)
Chemically Enhanced PC
N Removal Anoxic
Side Stream Treatment
Tertiary Filtration
Car
ollo
Tem
plat
eWat
erW
ave.
pptx
/10
0
20
40
60
80
100
0 15 30 45 60 75
% R
emov
al
SRT (d)
Acetaminophen
Literature
WERF Full-Scale
How Much SRT is Required for TOrC Removal?
0
20
40
60
80
100
0 15 30 45 60 75
% R
emov
al
SRT (d)
DEET
Literature
WERF Full-Scale
WERF Lab-Scale
TOrC SRT, days Acetaminophen 2 Caffeine 2 Ibuprofen 5 Naproxen 5 Bisphenol A 10 Triclosan 10 DEET 15 Gemfibrozil 15 Atenolol 15 BHA 15 Iopromide 15 Cimetidine 15 Diphenhydramine 20 Benzophenone 20 Trimehoprim 30
~ 80% TOrC Removal
Car
ollo
Tem
plat
eWat
erW
ave.
pptx
/11
SRT: A Driver for Nutrient and TOrC Removal
Acetaminophen Caffeine
Ibuprofen Naproxen
Bisphenol A Triclosan
DEET Gemfibrozil Atenolol BHA Iopromide Cimetidine
Diphenydramine Benzophenone
0 5 10 15 20 30
Trimethoprim
~ 80% TOrC Removal
Aerobic SRT, Days
Car
ollo
Tem
plat
eWat
erW
ave.
pptx
/12
Unaerated Versus Aerated Treatment MLR
Aerobic (70 %)
Anoxic (30 %) PE SE
Highly Sorptive
Moderately Biotransformed
Rapidly Biotransformed / Low Sorption
Car
ollo
Tem
plat
eWat
erW
ave.
pptx
/13
Biotransformation (Kb, L/g-d)
Recalcitrant <0.1
Moderate Slow 0.1-10
Rapid >10
Sorp
tion
(log
Kd)
Low
<2
.5
Carbamazepine Meprobamate
Primidone TCEP
Sucralose
DEET Sulfamethoxazole
Gemfibrozil Iopromide
Acetaminophen Caffeine
Naproxen Ibuprofen Atenolol
Sorp
tive
2.5-
3
TCPP Cimetidine Trimethoprim
Benzophenone Diphenhydramine
Bisphenol A
Effe
ctiv
e >3
Triclocarban
Triclosan Fluoxetine
Faster transformation during secondary treatment
Hig
her s
orpt
ion
durin
g se
cond
ary
treat
men
t Effect of Anoxic Zone on TOrC Removal
Significant Removal (Sorption)
Conc. Increase in
Liquid Phase
No Effect of Anoxic Zn.
Car
ollo
Tem
plat
eWat
erW
ave.
pptx
/14
10-20 mg/L TSS
Tertiary Filtration: How Do Lower Solids Relate to TOrC?
Tertiary Filtration
Secondary Clarification
2-5 mg/L TSS
Car
ollo
Tem
plat
eWat
erW
ave.
pptx
/15
Removal of TOrC by Tertiary Filtration
10-80% Additional Reduction Possible
Car
ollo
Tem
plat
eWat
erW
ave.
pptx
/16
Are MBRs More Efficient at TOrC Removal Than Conventional Secondary Treatment?
0
20
40
60
80
100
0 15 30 45 60 75
% R
emov
al
SRT (d)
Meprobamate
Literature
WERF Full-Scale
WERF Lab-Scale
MBR
MBR A2O / Bio P
A2O / Bio P
Recalcitrant Moderately slow
Car
ollo
Tem
plat
eWat
erW
ave.
pptx
/17
Sec. Effl. Accumulation of TOrC in High SRT Sludges
Sorption of TorC insignificant
TorC Load on WAS significant
MBR
RAS Waste Activated Sludge to
Solid Treatment
Sec. Infl. High SRT
Car
ollo
Tem
plat
eWat
erW
ave.
pptx
/18
High SRT Systems Expect High TOrC Concentrations in
Secondary Sludges
Car
ollo
Tem
plat
eWat
erW
ave.
pptx
/19
What Happens to the TOrC in Sludges During Digestion?
• 1-3% of Plant Influent Flow
• 15-20 % of Plant Ammonia Load
• Side Stream Treatment May Also Be Cost-Effective for TOrC Removal Load if flow proportionate
Sec. Influent Sec. Eff.
WAS to Digestion
RAS
Side Stream Treatment
Recycle from Solids
Dewatering
Car
ollo
Tem
plat
eWat
erW
ave.
pptx
/20
Summary and Conclusions • Process upgrades for nutrient removal add
synergistic benefits for the removal of specific TOrC groups.
• Study added value by quantifying anticipated removal for various treatment processes and TOrC groups.
• Indicator matrix can be mapped with TOrC not studied herein that are of environmental concern to assess removal efficiency (based on biodegradability and sorption characteristics).
• Results useful for risk assessment and process design for a defined required target effluent quality.
• Results can be used to assess different processes (e.g., Deammonification) – Monitoring Guidance
Car
ollo
Tem
plat
eWat
erW
ave.
pptx
/21
Biotransformation (Kb, L/g-d)
Recalcitrant <0.1
Moderate Slow 0.1-10
Rapid >10
Sorp
tion
(log
Kd)
Low
<2
.5
Carbamazepine Meprobamate
Primidone TCEP
Sucralose
DEET Sulfamethoxazole
Gemfibrozil Iopromide
Acetaminophen Caffeine
Naproxen Ibuprofen Atenolol
Sorp
tive
2.5-
3
TCPP Cimetidine Trimethoprim
Benzophenone Diphenhydramine
Bisphenol A
Effe
ctiv
e >3
Triclocarban
Triclosan Fluoxetine
Faster transformation during secondary treatment
Hig
her s
orpt
ion
durin
g se
cond
ary
treat
men
t
How Can Results Be Used to Assess Efficacy of Other Leading Processes in Industry?
Low DO – possible
desorption
Long SRT – Accumulation on
solids
Long SRT / High T / Low DO
biotransformation
Car
ollo
Tem
plat
eWat
erW
ave.
pptx
/22
Thank You!
Study Currently in Print
WERF CEC 4R08
Trace Organic Compound Indicator Removal During Conventional Wastewater Treatment
CONTACT INFORMATION
Tanja Rauch-Williams, Ph.D., P.E., [email protected]
www.werf.org/traceorganics